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ABSTRACT 
OBJECTIVES:  To find out the prevalence of metabolic syndrome 
(MBS) in women with PCOS and assess their strength of association. 
MATERIALS AND METHODS : Apparently healthy 200 non-pregnant 
females 15-35 years with normal thyroid profile and prolactin levels, 
having documented features of PCOS (according to Rotterdam criteria, 
2003) are selected from those attending the OPD of our hospital and 
assessed for presence of metabolic syndrome and clinical or laboratory 
evidence of hyperandrogenism (Ferrymen -Galaway score ≥ 7 is taken 
as cut off value for assessing hirsutism and elevated free testosterone  
> 2.57pg/ml). They are sub-divided in two age groups; 15-25years 
[Group 1] and 26 -35 years [Group 2] for  proper age matched 
association.  Each patient had undergone  a detailed clinical   
examination and a relevant  laboratory evaluation. Metabolic syndrome 
was diagnosed  according to NCEPATP III 2001 criteria for the 
presence of at least three of the five criteria. The National Cholesterol 
Education Program’s Adult Treatment Panel III (NCEPATP III) in 
2001,8 defines metabolic syndrome (MBS)as the presence of at least 
three of the following five criteria.1]. Abdominal/central obesity (waist 
circumference >88cms), 2] Serum triglycerides 150mg/dl or greater, 3] 
Serum HDL cholesterol less than 50 mg/dl, 4] BP 130/85 or greater, 5] 
Fasting blood sugar (FBS) 110mg/dl or more.  Ultrasonography– Trans 
abdominal (TAS) and or Trans vaginal (TVS) is done. unmarried 
women subjected to TAS. Blood samples for fasting blood sugar, fasting 
Insulin (FI-normal values ranges from2.6- 24.9μU/ml), free 
Testosterone (normal range between0.15- 2.57pg/ml), TSH and 
Prolactin (for exclusion) 
RESULTS: 65 subjects out of 200 (32.5%) met criteria for the MBS. 
35(71.5%) belonged to 26-35 years and 30(20.7%) in 15-25 years. 
Prevalence of waist circumference > 88 cm were noted in 72.5%, HDL 
cholesterol< 50 mg/dl in 48%, triglycerides ≥ 150 mg/dl in 34.5%, BP 
≥130/85 mm Hg in14.5% and FBS≥ 110 mg/dl in 9.5%. Women with 
higher insulin resistance and free testosterone levels significantly 
(P<0.01) correlated with higher prevalence of MBS.  
CONCLUSION: The metabolic syndrome and its individual 
components are common in PCOS, particularly among women with 
hyperinsulinemia and hyperandrogenism. 
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